| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,252 |
5,940 |
$703K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,185 |
4,962 |
$476K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,119 |
4,912 |
$342K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,138 |
1,960 |
$130K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,302 |
1,247 |
$109K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,235 |
2,128 |
$70K |
| G0378 |
Hospital observation service, per hour |
308 |
181 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,977 |
7,103 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,401 |
9,085 |
$48K |
| 80050 |
General health panel |
939 |
931 |
$44K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
260 |
254 |
$43K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,793 |
1,760 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,464 |
1,348 |
$32K |
| 84450 |
|
5,944 |
5,603 |
$31K |
| 83615 |
|
5,751 |
5,402 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
894 |
887 |
$31K |
| 93976 |
|
453 |
439 |
$30K |
| 82247 |
|
5,730 |
5,371 |
$29K |
| 83735 |
|
4,823 |
4,378 |
$26K |
| 82150 |
|
5,737 |
5,396 |
$22K |
| 84075 |
|
4,789 |
4,508 |
$22K |
| 80061 |
Lipid panel |
1,571 |
1,553 |
$21K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
258 |
256 |
$20K |
| 80053 |
Comprehensive metabolic panel |
1,596 |
1,389 |
$16K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
41 |
41 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,057 |
1,859 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
785 |
762 |
$15K |
| 83690 |
|
3,405 |
3,193 |
$13K |
| 70450 |
Computed tomography, head or brain; without contrast material |
226 |
220 |
$12K |
| 84484 |
|
1,842 |
1,531 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
196 |
189 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,733 |
1,606 |
$11K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
58 |
58 |
$11K |
| 84460 |
|
1,906 |
1,833 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
1,522 |
1,407 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
465 |
454 |
$11K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
465 |
454 |
$11K |
| 85730 |
|
1,688 |
1,582 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
238 |
232 |
$9K |
| 87476 |
|
242 |
232 |
$9K |
| 82607 |
|
735 |
727 |
$9K |
| 82550 |
|
1,763 |
1,585 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
548 |
421 |
$8K |
| 87040 |
|
441 |
409 |
$8K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
239 |
234 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
944 |
933 |
$6K |
| 84439 |
|
827 |
819 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
94 |
93 |
$6K |
| 85610 |
|
2,098 |
1,889 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
246 |
244 |
$5K |
| 82746 |
|
441 |
441 |
$5K |
| 81001 |
|
2,043 |
1,911 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
382 |
373 |
$5K |
| 76536 |
|
92 |
91 |
$4K |
| 86780 |
|
272 |
271 |
$4K |
| 84145 |
|
198 |
188 |
$4K |
| 83605 |
|
626 |
557 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
75 |
70 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
81 |
77 |
$3K |
| 82728 |
|
276 |
271 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
322 |
257 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
99 |
98 |
$3K |
| 83540 |
|
320 |
313 |
$3K |
| 82043 |
|
308 |
306 |
$2K |
| 84702 |
|
152 |
104 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
49 |
49 |
$2K |
| 73630 |
|
243 |
228 |
$2K |
| 81003 |
|
843 |
782 |
$2K |
| 97161 |
|
66 |
61 |
$2K |
| 83880 |
|
84 |
76 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
52 |
52 |
$2K |
| 80076 |
|
247 |
233 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 73610 |
|
122 |
120 |
$2K |
| 81025 |
|
550 |
522 |
$2K |
| 85378 |
|
220 |
211 |
$2K |
| 87430 |
|
290 |
281 |
$2K |
| 87070 |
|
308 |
295 |
$2K |
| 86140 |
|
688 |
640 |
$2K |
| 84436 |
|
197 |
194 |
$2K |
| 87186 |
|
218 |
204 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
32 |
26 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
833 |
622 |
$2K |
| 86850 |
|
213 |
198 |
$2K |
| 76830 |
Ultrasound, transvaginal |
41 |
40 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
226 |
214 |
$2K |
| 87807 |
|
113 |
109 |
$1K |
| 87340 |
|
96 |
96 |
$1K |
| 80305 |
|
160 |
151 |
$1K |
| 86038 |
|
88 |
86 |
$1K |
| 84479 |
|
153 |
152 |
$1K |
| 85651 |
|
430 |
409 |
$1K |
| 72110 |
|
73 |
72 |
$1K |
| 83550 |
|
241 |
235 |
$1K |
| 73130 |
|
82 |
75 |
$932.36 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
28 |
28 |
$902.63 |
| 86901 |
|
214 |
199 |
$784.74 |
| 86900 |
|
214 |
199 |
$779.20 |
| 82565 |
|
151 |
145 |
$767.79 |
| 86803 |
|
38 |
38 |
$731.01 |
| 73030 |
|
65 |
59 |
$722.38 |
| 87088 |
|
117 |
111 |
$717.79 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
32 |
27 |
$690.50 |
| 82553 |
|
77 |
68 |
$646.74 |
| 87081 |
|
104 |
104 |
$621.36 |
| 82248 |
|
86 |
86 |
$603.42 |
| 94729 |
|
28 |
28 |
$580.90 |
| 87077 |
|
94 |
89 |
$490.08 |
| 84550 |
|
83 |
78 |
$467.41 |
| 84153 |
|
17 |
17 |
$425.63 |
| 86617 |
|
14 |
14 |
$400.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,263 |
1,102 |
$385.87 |
| 84403 |
|
14 |
13 |
$385.29 |
| 82951 |
|
27 |
26 |
$369.26 |
| 86762 |
|
17 |
17 |
$365.21 |
| 94727 |
|
26 |
26 |
$360.65 |
| 74019 |
|
24 |
24 |
$341.82 |
| 94060 |
|
42 |
42 |
$324.36 |
| 86787 |
|
15 |
15 |
$270.17 |
| 82784 |
|
14 |
12 |
$238.82 |
| 94664 |
|
27 |
26 |
$227.63 |
| 85027 |
|
32 |
27 |
$214.27 |
| 36415 |
Collection of venous blood by venipuncture |
1,796 |
1,467 |
$212.56 |
| 83001 |
|
12 |
12 |
$211.75 |
| 84100 |
|
32 |
29 |
$194.24 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
767 |
753 |
$193.40 |
| 74018 |
|
14 |
14 |
$181.38 |
| 84165 |
|
12 |
12 |
$163.36 |
| 73560 |
|
16 |
14 |
$161.88 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
45 |
36 |
$145.47 |
| 85007 |
|
33 |
27 |
$128.25 |
| 73502 |
|
12 |
12 |
$108.27 |
| 86376 |
|
14 |
13 |
$102.34 |
| J3490 |
Unclassified drugs |
223 |
192 |
$99.50 |
| 84703 |
|
12 |
12 |
$90.01 |
| 86431 |
|
13 |
12 |
$84.77 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$83.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,756 |
1,462 |
$68.36 |
| 84520 |
|
14 |
13 |
$62.94 |
| 87205 |
|
13 |
12 |
$33.53 |
| J2704 |
Injection, propofol, 10 mg |
1,194 |
1,136 |
$28.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
935 |
833 |
$8.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
583 |
508 |
$6.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,312 |
1,028 |
$5.93 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
987 |
857 |
$1.48 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
901 |
833 |
$0.60 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
31 |
28 |
$0.00 |
| 3052F |
|
13 |
13 |
$0.00 |
| 88304 |
|
39 |
39 |
$0.00 |
| 3044F |
|
161 |
158 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
13 |
12 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
117 |
116 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
33 |
25 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
12 |
$0.00 |
| 3051F |
|
27 |
27 |
$0.00 |